Immunology Practice Questions

Q: Recurrent Neisseria infections are predisposed by which of the following?

Late complement component deficiency. ### Explanation **Correct Answer: A. Late complement component deficiency** **The Medical Concept:** The complement system is a crucial arm of innate immunity. The **late complement components (C5, C6, C7, C8, and C9)** assemble to form the **Membrane Attack Complex (MAC)**. The MAC is essential for the lysis of Gram-negative bacteria, particularly *Neisseria* species (*N. meningitidis* and *N. gonorrhoeae*), which have thin peptidoglycan layers. Individuals with deficiencies in these components cannot form the MAC, leaving them uniquely susceptible to recurrent, disseminated Neisserial infections. **Analysis of Incorrect Options:** * **B. Properdin deficiency:** Properdin stabilizes the alternative pathway C3 convertase. While its deficiency can increase susceptibility to *Neisseria*, it is much rarer than late component deficiencies and is X-linked. Late component deficiency remains the classic, most high-yield association. * **C. Early complement component deficiency (C1, C4, C2):** These are primarily involved in the classical pathway and the clearance of immune complexes. Deficiencies here typically predispose patients to **Systemic Lupus Erythematosus (SLE)** and pyogenic infections (e.g., *S. pneumoniae*), rather than specific *Neisseria* susceptibility. * **D. C1 esterase deficiency:** This leads to **Hereditary Angioedema** due to the overproduction of bradykinin. It is not associated with an increased risk of bacterial infections. **High-Yield Clinical Pearls for NEET-PG:** * **C3 deficiency:** The most severe complement deficiency; predisposes to recurrent pyogenic infections and Type III hypersensitivity reactions. * **CH50 Assay:** Used to screen for classical pathway and MAC deficiencies. * **Mnemonic:** "Late is for Lysis" — C5-C9 are needed for lysis of *Neisseria*. * **Vaccination:** Patients with terminal complement deficiencies must receive the meningococcal vaccine.

Q: Where are B cells processed?

Bone marrow. **Explanation:** The development of B cells occurs in two distinct phases: **antigen-independent** (maturation) and **antigen-dependent** (activation). **Why Bone Marrow is correct:** In humans, the **Bone Marrow** is the primary lymphoid organ responsible for the generation and maturation of B cells. Here, hematopoietic stem cells undergo gene rearrangement to produce a functional B-cell receptor (BCR). This process is known as "processing" or "central maturation." Once B cells express IgM on their surface (immature B cells), they leave the bone marrow to seed peripheral lymphoid organs. (Note: In birds, this occurs in the *Bursa of Fabricius*, which is the origin of the letter "B" in B cells). **Why other options are incorrect:** * **Liver:** This is the primary site of B-cell production during **fetal life** (extramedullary hematopoiesis). However, in adults, this function shifts entirely to the bone marrow. * **Spleen & Lymph Nodes:** These are **secondary lymphoid organs**. They are sites where mature B cells encounter antigens, undergo activation, and differentiate into plasma cells. They do not "process" or create the B cells initially. **High-Yield Clinical Pearls for NEET-PG:** * **T-cell Processing:** Occurs in the **Thymus**. * **Negative Selection:** The process in the bone marrow where B cells that react strongly to "self-antigens" are eliminated or undergo **receptor editing** to prevent autoimmunity. * **Bruton’s Agammaglobulinemia:** A clinical condition where B-cell maturation is arrested at the pre-B stage due to a mutation in the *Btk* gene, leading to a lack of mature B cells and antibodies.

Q: Interleukin 1 (IL-1) is a potent cytokine. It is best described by which one of the following statements?

It can be produced by natural killer cells. ### Explanation **Interleukin-1 (IL-1)** is a key pro-inflammatory cytokine primarily associated with the innate immune response. **Why Option A is Correct:** While **monocytes and macrophages** are the primary sources of IL-1, it is also produced by a variety of other cells, including **Natural Killer (NK) cells**, B cells, dendritic cells, endothelial cells, and epithelial cells. In the context of NEET-PG, it is crucial to remember that IL-1 production is not exclusive to myeloid cells. **Analysis of Incorrect Options:** * **Option B:** This statement is partially true but less accurate than A. IL-1 acts as a co-stimulator for T-cell activation (enhancing IL-2 production); however, its primary role is as an endogenous pyrogen and a mediator of acute-phase responses. * **Option C:** IL-1 is not multimeric. It exists in two distinct **monomeric** forms, **IL-1α and IL-1β**, which are encoded by separate genes but bind to the same receptor. * **Option D:** This is factually incorrect. Synthesis of IL-1 is significantly **increased and induced** in activated macrophages, especially upon exposure to PAMPs (like LPS) via Toll-like receptors. --- ### High-Yield Clinical Pearls for NEET-PG: * **The "Fever" Cytokine:** IL-1 is a potent **endogenous pyrogen**. It acts on the anterior hypothalamus to increase prostaglandin E2 (PGE2) synthesis, raising the thermoregulatory set point. * **The Inflammasome Connection:** IL-1β is synthesized as an inactive precursor (pro-IL-1β). It requires cleavage by **Caspase-1** within the **NLRP3 inflammasome** complex to become biologically active. * **Acute Phase Response:** Along with IL-6 and TNF-α, IL-1 stimulates the liver to produce acute-phase reactants (e.g., CRP, Fibrinogen). * **Clinical Correlation:** **Anakinra** is a recombinant IL-1 receptor antagonist used in the treatment of Rheumatoid Arthritis and Cryopyrin-Associated Periodic Syndromes (CAPS).

Q: Which of the following cell surface markers are associated with T helper cells?

CD2+ CD3+ CD4+ CD8- TCR+ cell. **Explanation:** The identification of T-lymphocyte subsets is based on the presence of specific **Cluster of Differentiation (CD)** markers. All mature T-cells are characterized by the presence of **CD2** (an adhesion molecule/LFA-2), **CD3** (part of the T-cell receptor complex for signal transduction), and a functional **TCR** (T-cell receptor). **1. Why Option C is Correct:** T helper (Th) cells are defined as **CD4+** cells. They recognize antigens presented by **MHC Class II** molecules. Therefore, a mature T helper cell will express **CD2+, CD3+, CD4+, and TCR+**, while being negative for CD8. **2. Analysis of Incorrect Options:** * **Option A:** This represents a "null cell" or a very early pro-T cell (double negative) found in the thymus before maturation. It lacks the essential markers of a functional T-lymphocyte. * **Option B:** This describes a "double-negative" T-cell. While these exist in small numbers in the peripheral blood (often γδ T-cells), they do not function as classical T helper cells. * **Option D:** This describes a **Cytotoxic T-lymphocyte (CTL)**. These cells are **CD8+** and recognize antigens presented by **MHC Class I** molecules. **Clinical Pearls for NEET-PG:** * **CD3** is the most specific marker for all T-cells. * **CD4:CD8 Ratio:** In a healthy individual, the normal ratio is approximately **2:1**. * **HIV Pathogenesis:** HIV selectively infects CD4+ cells by binding to the CD4 molecule (using gp120), leading to a depletion of T helper cells and a reversal of the CD4:CD8 ratio. * **MHC Restriction Rule:** CD4 x II = 8 and CD8 x I = 8 (The product of the CD marker and the MHC class always equals 8).

Q: Which antibody has the maximum concentration in gastrointestinal secretions?

IgA. **Explanation:** The correct answer is **IgA**. **Why IgA is correct:** Immunoglobulin A (IgA) is the primary antibody involved in **mucosal immunity**. In the body, it exists in two forms: a monomer in the serum and a **dimer** in secretions. Secretory IgA (sIgA) is specifically adapted to survive in harsh environments like the gastrointestinal (GI) tract. It contains a **J-chain** that holds the dimer together and a **secretory component** (derived from epithelial cells) that protects the antibody from proteolytic enzymes present in GI secretions. It acts by "immune exclusion," preventing the attachment of pathogens to mucosal surfaces. **Why other options are incorrect:** * **IgG:** This is the most abundant antibody in the **serum** (75-80%) and provides systemic immunity. It is the only antibody that crosses the placenta but is not the primary defender in GI secretions. * **IgM:** This is the largest antibody (pentamer) and the first to appear in a primary immune response. While it also contains a J-chain and can be secreted onto mucosal surfaces in IgA-deficient individuals, its concentration is significantly lower than IgA. * **IgD:** Found primarily on the surface of B-cells as a receptor; it has no known major role in mucosal secretions. **NEET-PG High-Yield Pearls:** * **Most abundant Ig overall:** IgG (Serum) vs. **Most produced Ig daily:** IgA (due to the vast surface area of mucous membranes). * **Selective IgA Deficiency:** The most common primary immunodeficiency; patients often present with recurrent GI infections (e.g., *Giardia*) and respiratory infections. * **Breast Milk:** IgA is the predominant antibody in colostrum, providing passive mucosal immunity to the neonate.

Q: Which theory is most commonly accepted for antibody production?

Clonal selection theory. **Explanation:** The **Clonal Selection Theory**, proposed by **Frank Macfarlane Burnet** in 1957, is the most widely accepted model for antibody production and immune response. **1. Why Clonal Selection Theory is Correct:** This theory states that the body contains a vast repertoire of pre-existing B-lymphocytes, each carrying a unique surface receptor for a specific antigen. When an antigen enters the body, it "selects" the specific lymphocyte that matches its shape. This selected cell is then activated to proliferate (clone itself) and differentiate into: * **Plasma cells:** Which secrete large quantities of antibodies specific to that antigen. * **Memory cells:** Which provide long-term immunity. **2. Why Other Options are Incorrect:** * **Direct Template Theory (Pauling):** Suggested that antigens act as a physical mold or "template" around which a generic antibody protein folds. This was proven wrong because protein folding is determined by amino acid sequences, not external templates. * **Indirect Template Theory:** Proposed that the antigen modifies the DNA or protein-synthesis machinery to produce specific antibodies. This contradicts the central dogma of molecular biology. * **Natural Selection Theory (Jerne):** Suggested that all possible antibodies already circulate in the blood, and the antigen simply binds to one and transports it to a cell for replication. While it introduced the idea of pre-existing diversity, it lacked the cellular mechanism of clonal expansion. **High-Yield Clinical Pearls for NEET-PG:** * **Key Scientist:** Burnet (Nobel Prize winner). * **Self-Tolerance:** Clonal selection explains how the body avoids autoimmunity; clones that react to "self-antigens" are deleted during embryonic development (**Clonal Deletion**). * **Monoclonal Antibodies:** The concept of "one cell, one antibody" is the basis for producing monoclonal antibodies (Hybridoma technology).

Q: CD4 lymphocytes (helper cells) recognize which of the following antigens?

HLA class II antigen. ### Explanation The recognition of antigens by T-lymphocytes is governed by the principle of **MHC Restriction**. T-cells do not recognize free-floating antigens; they only respond to processed antigenic peptides presented on **Major Histocompatibility Complex (MHC)** molecules, also known as **Human Leukocyte Antigens (HLA)** in humans. **Why Option B is Correct:** CD4+ T-cells (Helper T-cells) are restricted to **HLA Class II** molecules. These antigens are primarily expressed on **Professional Antigen-Presenting Cells (APCs)** such as macrophages, B-cells, and dendritic cells. When an APC engulfs an exogenous pathogen, it presents the peptide via HLA Class II to the CD4+ cell, triggering the release of cytokines and the orchestration of the adaptive immune response. **Why Other Options are Incorrect:** * **Option A (HLA Class I):** These are recognized by **CD8+ T-cells** (Cytotoxic T-cells). HLA Class I molecules are found on almost all nucleated cells and present endogenous antigens (like viral or tumor proteins) to signal the destruction of the infected cell. * **Option C (HLA Class III):** These genes encode various components of the complement system (C2, C4), tumor necrosis factor (TNF), and heat shock proteins. They are **not** involved in the direct presentation of antigens to T-cells. **High-Yield NEET-PG Pearls:** 1. **The Rule of 8:** A simple mnemonic to remember MHC restriction: * **CD4 × MHC II = 8** * **CD8 × MHC I = 8** 2. **HLA Loci:** Class I includes HLA-A, B, and C. Class II includes HLA-DP, DQ, and DR. 3. **Exogenous vs. Endogenous:** CD4/MHC II deals with exogenous (extracellular) antigens, while CD8/MHC I deals with endogenous (intracellular) antigens.

Q: Innate immunity is stimulated by which part of bacteria that acts as a danger signal?

Cell wall carbohydrate sequence. **Explanation:** Innate immunity relies on the recognition of conserved molecular structures known as **Pathogen-Associated Molecular Patterns (PAMPs)**. These are recognized by **Pattern Recognition Receptors (PRRs)**, such as Toll-like receptors (TLRs), on host immune cells. **Why Option A is correct:** The **cell wall carbohydrate sequences** (such as peptidoglycan, lipopolysaccharide/LPS, and mannose) are classic examples of PAMPs. These structures are essential for bacterial survival and are unique to microbes, allowing the innate immune system to identify them as "danger signals" or "non-self." For instance, LPS (found in Gram-negative cell walls) is a potent stimulator of TLR-4, triggering a robust inflammatory response. **Why the other options are incorrect:** * **B. Flagella:** While flagellin (the protein in flagella) is a PAMP recognized by TLR-5, the question specifically asks for the primary "danger signal" often associated with structural sequences. In the hierarchy of innate triggers, cell wall components are the most ubiquitous and potent initiators. * **C. Bacterial cell membrane:** While membranes contain phospholipids, they are structurally similar to host membranes. The innate system specifically targets the **cell wall** (which humans lack) rather than the generic lipid bilayer. * **D. Nucleus:** Bacteria are prokaryotes and **do not possess a nucleus**. Their genetic material is organized in a nucleoid. **High-Yield Clinical Pearls for NEET-PG:** * **TLR-4** recognizes LPS (Gram-negative bacteria). * **TLR-2** recognizes Peptidoglycan and Teichoic acid (Gram-positive bacteria). * **TLR-5** recognizes Flagellin. * **TLR-9** recognizes unmethylated CpG DNA. * **DAMPs (Damage-Associated Molecular Patterns):** These are endogenous danger signals released from *host* cells during injury (e.g., Heat shock proteins, Uric acid).

Q: Which are the terminal components of the complement system?

C7, C8, C9. **Explanation:** The complement system consists of a cascade of proteins that mediate inflammation and pathogen destruction. The **Terminal Complement Complex (TCC)**, also known as the **Membrane Attack Complex (MAC)**, is the final effector stage of all three complement pathways (Classical, Alternative, and Lectin). The MAC is formed by the sequential assembly of five proteins: **C5b, C6, C7, C8, and C9**. * The process begins when C5 is cleaved into C5a and C5b. * C5b binds to C6 and C7 to form a complex that inserts into the target cell membrane. * C8 then binds, followed by the polymerization of multiple **C9** molecules, which form a transmembrane pore leading to osmotic lysis of the cell. * While C5b-C9 constitutes the entire MAC, **C7, C8, and C9** are specifically categorized as the terminal components that complete the pore structure. **Analysis of Options:** * **Option B (Correct):** C7, C8, and C9 are the final structural components that anchor and form the functional pore. * **Option A & D:** These include C6 and C5/C7. While C5b and C6 are part of the MAC initiation, they are considered "late-acting" but not the final terminal steps compared to C7-C9. * **Option C:** C3, C4, and C5 are "early" components involved in opsonization (C3b) and the formation of C3/C5 convertases. **NEET-PG Clinical Pearls:** 1. **Deficiency:** Patients with deficiencies in terminal components (C5-C9) have a high susceptibility to recurrent **Neisseria** infections (Meningitis and Gonorrhea). 2. **Inhibitor:** **CD59 (Protectin)** is a host cell protein that inhibits the assembly of the MAC to prevent self-destruction. 3. **Anaphylatoxins:** C3a, C4a, and **C5a** (the most potent) are byproducts that trigger mast cell degranulation.

Question 1

Recurrent Neisseria infections are predisposed by which of the following?

Accepted Answer

Late complement component deficiency

Answer

Properdin deficiency

Answer

Early complement component deficiency

Answer

C1 esterase deficiency

Question 2

Where are B cells processed?

Accepted Answer

Bone marrow

Answer

Liver

Answer

Spleen

Answer

Lymph nodes

Question 3

Interleukin 1 (IL-1) is a potent cytokine. It is best described by which one of the following statements?

Accepted Answer

It can be produced by natural killer cells

Answer

It exerts its effects on T and B cells as a costimulator

Answer

It is multimeric and consists of more than one protein

Answer

Synthesis of IL-1 is inhibited in activated macrophages

Question 4

Which statement is not true regarding superantigens?

Accepted Answer

Bind to the antigen-binding groove (cleft) in the MHC class II molecule.

Answer

Bind T cells irrespective of the antigen specificity of the T cell receptor.

Answer

Bind directly to both MHC class II and the T cell receptor, causing T cell activation.

Answer

Bind directly to the lateral aspect of the T cell receptor.

Question 5

Which of the following cell surface markers are associated with T helper cells?

Accepted Answer

CD2+ CD3+ CD4+ CD8- TCR+ cell

Answer

CD2- CD3- CD4- CD8- TCR- cell

Answer

CD2+ CD3+ CD4- CD8- TCR+ cell

Answer

CD2+ CD3+ CD4- CD8+ TCR+ cell

Question 6

Which antibody has the maximum concentration in gastrointestinal secretions?

Accepted Answer

IgA

Answer

IgG

Answer

IgM

Answer

IgD

Question 7

Which theory is most commonly accepted for antibody production?

Accepted Answer

Clonal selection theory

Answer

Direct template theory

Answer

Indirect template theory

Answer

Natural selection theory

Question 8

CD4 lymphocytes (helper cells) recognize which of the following antigens?

Accepted Answer

HLA class II antigen

Answer

HLA class I antigen

Answer

HLA class III antigen

Answer

None of the above

Question 9

Innate immunity is stimulated by which part of bacteria that acts as a danger signal?

Accepted Answer

Cell wall carbohydrate sequence

Answer

Flagella

Answer

Bacterial cell membrane

Answer

Nucleus

Question 10

Which are the terminal components of the complement system?

Accepted Answer

C7, C8, C9

Answer

C6, C7, C8

Answer

C3, C4, C5

Answer

C5, C6, C7

Immunology — MCQs

Immunology — MCQs

On this page

Practice by Chapter

Want unlimited practice?